INO:NASDAQ
Inovio Pharmaceuticals Inc
US$ १.०१
arrow_upward
+१.००%(+०.०१००) 1D
US$ १.०८
arrow_upward
+६.९३% (+०.०७०)bedtimeAfter hours
Closed: अक्टोबर २०, १६:००:०१ GMT-४ · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for INO...
Open
US$ १.०१
High
US$ १.०६
Low
US$ ०.९९
Mkt. cap
१०.४४ करोड
Avg. vol.
२८.४५ लाख
Volume
१.०५ करोड
52-wk high
US$ २.७२
52-wk low
US$ ०.५७
EPS
-US$ १.१७
Beta
१.६१
Shares outstanding
१०.३४ करोड
No. of employees
११२
Open
US$ १.०१
High
US$ १.०६
Low
US$ ०.९९
Mkt. cap
१०.४४ करोड
Avg. vol.
२८.४५ लाख
Volume
१.०५ करोड
52-wk high
US$ २.७२
52-wk low
US$ ०.५७
EPS
-US$ १.१७
Beta
१.६१
Shares outstanding
१०.३४ करोड
No. of employees
११२
News stories
From web sources and news partners
GuruFocus
·
३९ मिनेट पहिले
Inovio Pharmaceuticals (INO) Awarded $80.4M in Legal Case Amid F
News Corp
·
१ घण्टा पहिले
Inovio Pharmaceuticals Inc. stock underperforms Tuesday when compared to competitors despite daily gains
Benzinga
·
१ घण्टा पहिले
12 Health Care Stocks Moving In Tuesday's After-Market Session
Investing.com UK
·
२ घण्टा पहिले
Inovio secures $80.4 million judgment against VGXI, GeneOne By Investing.com
Profile
Inovio Pharmaceuticals, Inc. is an American biotechnology company focused on the discovery, development, and commercialization of synthetic DNA products for treating cancers and infectious diseases. In April 2020, Inovio was among some 100 companies, academic centers, or research organizations developing a vaccine candidate for treating people infected with COVID-19, with more than 170 total vaccine candidates in development. Wikipedia
About Inovio Pharmaceuticals Inc